Overview
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 13, 2012 | Cancer diagnostics firm that can enable personalized medicine raises $13M in series B financing | “Epic’s technology has achieved an unprecedented level of sensitivity in detecting circulating tumor cells to develop crucial cancer diagnostics for the millions of patients who need to understand whether their treatment is working and the ... |
| Jul 27, 2012 | Health IT firm focused on personalized medicine raising up to $10.1 million | Location: Auburndale, Massachusetts. Solution/product: With the goal of enabling personalized medicine, the company has developed a cloud-based analytical solution that it says can transform vast amounts of technical data into relevant insi... |
| Jan 31, 2012 | Personalized medicine test maker secures $8M line of credit | An AssureRx spokesman declined to provide further detail on the company’s new products. However, in the past, AssureRx has said that future products could include tests that help doctors choose medications for patients who have neurodegener... |
| Mar 25, 2011 | Personalized medicine firm AssureRx closes $11M Series B investment | The financing was led by California-based Claremont Creek Ventures and Sequoia Capital, and included participation of existing investors North Coast Angel Fund, Cincinnati Children’s Hospital Medical Center, Mayo Clinic and CincyTech, as we... |
| Cancer diagnostics firm that can enable personalized medicine raises $13M in series B financing | San Diego-based biotech firm Epic Sciences announced Tuesday that the company has raised $13 million to pursue its molecular diagnostics technology that can better detect and monitor cancer as well as enable personalize cancer treatment. In... | |
| Health IT firm focused on personalized medicine raising up to $10.1 million | Company name: PanGenX (formerly the Pharmacogenetics Clinical Advisory Board). Industry: Health IT/data. Location: Auburndale, Massachusetts. Solution/product: With the goal of enabling personalized medicine, the company has developed a clo... | |
| Personalized medicine test maker secures $8M line of credit | Behavioral health personalized medicine company AssureRx Health has secured an $8 million line of credit as it looks to boost adoption of its genetic screening test for psychiatric drugs. Along with an $11 million series B round of funding ... | |
| Personalized medicine firm AssureRx closes $11M Series B investment | Personalized medicine test maker AssureRx Health has closed an $11 million Series B round of funding. The Cincinnati-area company will use the funding to expand sales and marketing for its GeneSightRx test, which helps doctors pick the righ... |
Reviews 0
FAQ about Diabetes Lab
What has the press written about Diabetes Lab?
Parsers VC has collected 9 articles mentioning Diabetes Lab, among them “Cancer diagnostics firm that can enable personalized medicine raises $13M in series B financing” (Nov 13, 2012) and “Health IT firm focused on personalized medicine raising up to $10.1 million” (Jul 27, 2012).
Is Diabetes Lab still active?
Yes, Diabetes Lab is active; its latest activity on Parsers VC dates from Jul 8, 2019.